A detailed history of Sprucegrove Investment Management LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Sprucegrove Investment Management LTD holds 55,609 shares of BDX stock, worth $12.7 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
55,609
Previous 55,709 0.18%
Holding current value
$12.7 Million
Previous $13 Million 2.98%
% of portfolio
0.91%
Previous 0.85%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$221.47 - $242.41 $22,147 - $24,241
-100 Reduced 0.18%
55,609 $13.4 Million
Q2 2024

Aug 12, 2024

BUY
$225.07 - $246.17 $157,549 - $172,319
700 Added 1.27%
55,709 $13 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $9.57 Million - $10.2 Million
41,000 Added 292.67%
55,009 $13.6 Million
Q4 2023

Jan 29, 2024

SELL
$232.24 - $267.23 $23,224 - $26,723
-100 Reduced 0.71%
14,009 $3.42 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $107,822 - $119,958
-423 Reduced 2.91%
14,109 $3.65 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $469,151 - $522,149
-1,968 Reduced 11.93%
14,532 $3.84 Million
Q1 2023

May 10, 2023

SELL
$229.71 - $259.35 $252,681 - $285,285
-1,100 Reduced 6.25%
16,500 $4.08 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $1.77 Million - $2.08 Million
-8,100 Reduced 31.52%
17,600 $4.48 Million
Q3 2022

Nov 09, 2022

SELL
$51.03 - $264.23 $877,716 - $4.54 Million
-17,200 Reduced 40.09%
25,700 $5.73 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $9.37 Million - $11 Million
-39,900 Reduced 48.19%
42,900 $10.6 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $14 Million - $15.5 Million
-57,400 Reduced 40.94%
82,800 $22 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $3.5 Million - $3.81 Million
-15,200 Reduced 9.78%
140,200 $35.3 Million
Q3 2021

Nov 08, 2021

BUY
$232.72 - $256.47 $1.56 Million - $1.72 Million
6,700 Added 4.51%
155,400 $38.2 Million
Q2 2021

Aug 10, 2021

SELL
$232.65 - $254.58 $442,035 - $483,702
-1,900 Reduced 1.26%
148,700 $36.2 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $6.2 Million - $6.86 Million
-26,700 Reduced 15.06%
150,600 $36.6 Million
Q4 2020

Feb 05, 2021

BUY
$221.92 - $245.94 $21.6 Million - $23.9 Million
97,200 Added 121.35%
177,300 $44.4 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $7.06 Million - $9.05 Million
32,700 Added 68.99%
80,100 $18.6 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $4.01 Million - $4.81 Million
-18,250 Reduced 27.8%
47,400 $11.3 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $469,656 - $669,624
-2,400 Reduced 3.53%
65,650 $15.1 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $3.06 Million - $3.45 Million
12,924 Added 23.44%
68,050 $18.5 Million
Q3 2019

Nov 12, 2019

BUY
$230.58 - $256.08 $6.52 Million - $7.24 Million
28,276 Added 105.31%
55,126 $13.9 Million
Q2 2019

Aug 12, 2019

SELL
$217.4 - $246.08 $630,460 - $713,632
-2,900 Reduced 9.75%
26,850 $6.77 Million
Q1 2019

May 07, 2019

SELL
$206.05 - $248.17 $824,200 - $992,680
-4,000 Reduced 11.85%
29,750 $7.43 Million
Q4 2018

Feb 08, 2019

SELL
$204.73 - $257.93 $737,028 - $928,548
-3,600 Reduced 9.64%
33,750 $7.61 Million
Q3 2018

Nov 13, 2018

SELL
$233.07 - $256.0 $3.01 Million - $3.3 Million
-12,900 Reduced 25.67%
37,350 $9.75 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $561,870 - $631,395
-2,700 Reduced 5.1%
50,250 $12 Million
Q1 2018

May 11, 2018

SELL
$205.46 - $240.27 $678,018 - $792,891
-3,300 Reduced 5.87%
52,950 $11.5 Million
Q4 2017

Feb 09, 2018

SELL
$189.0 - $222.64 $1.17 Million - $1.38 Million
-6,200 Reduced 9.93%
56,250 $12 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $11.7 Million - $12.4 Million
62,450
62,450 $12.2 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Sprucegrove Investment Management LTD Portfolio

Follow Sprucegrove Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sprucegrove Investment Management LTD with notifications on news.